Related references
Note: Only part of the references are listed.Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Philippe Colson et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
Chih-Cheng Lai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach
Manojit Bhattacharya et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV
Vargab Baruah et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Antibodies to watch in 2020
Helene Kaplon et al.
MABS (2020)
Coronavirus puts drug repurposing on the fast track
Charlotte Harrison
NATURE BIOTECHNOLOGY (2020)
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Kimiyasu Shiraki et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
The COVID-19 epidemic
Thirumalaisamy P. Velavan et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2020)
Enhancing the immunogenicity of a DNA vaccine against Streptococcus mutans by attenuating the inhibition of endogenous miR-9
Rong Jia et al.
VACCINE (2020)
Another coronavirus, another epidemic, another warning
Gregory A. Poland
VACCINE (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
Weilong Shang et al.
NPJ VACCINES (2020)
COVID-19 infection and rheumatoid arthritis: Faraway, so close!
Ennio Giulio Favalli et al.
AUTOIMMUNITY REVIEWS (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
The epidemiology, diagnosis and treatment of COVID-19
Pan Zhai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase
Jrhau Lung et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Treatment options for COVID-19: The reality and challenges
Shio-Shin Jean et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650
Qiu-dong Su et al.
VACCINE (2020)
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Yu-chen Cao et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
Kuldeep Dhama et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing as the of SARS-CoV-2
Ye Qiu et al.
MICROBES AND INFECTION (2020)
Chemistry and Biology of SARS-CoV-2
Alexander Domling et al.
CHEM (2020)
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
Eun Kim et al.
EBIOMEDICINE (2020)
Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
Hsin- Shih et al.
BIOMEDICAL JOURNAL (2020)
Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
Pradip Dashraath et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19
Rupal Ojha et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
Muhammad Adnan Shereen et al.
JOURNAL OF ADVANCED RESEARCH (2020)
Candidate drugs against SARS-CoV-2 and COVID-19
Dwight L. McKee et al.
PHARMACOLOGICAL RESEARCH (2020)
Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status
Tarek Mohamed Abd El-Aziz et al.
INFECTION GENETICS AND EVOLUTION (2020)
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
Abhjieet Pandey et al.
LIFE SCIENCES (2020)
COVID-19 for the Cardiologist Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies
Deepak Atri et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Robert A Feldman et al.
VACCINE (2019)
A rapid strategy for constructing novel simian adenovirus vectors with high viral titer and expressing highly antigenic proteins applicable for vaccine development
Shengxue Luo et al.
VIRUS RESEARCH (2019)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity
Shinu John et al.
VACCINE (2018)
Dissolving microneedles for transdermal drug delivery: Advances and challenges
Kevin Ita
BIOMEDICINE & PHARMACOTHERAPY (2017)
Modified mRNA Vaccines Protect against Zika Virus Infection
Justin M. Richner et al.
CELL (2017)
Transdermal Delivery of Drugs with Microneedles-Potential and Challenges
Kevin Ita
PHARMACEUTICS (2015)
Nonviral delivery of self-amplifying RNA vaccines
Andrew J. Geall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Enzymatic assembly of DNA molecules up to several hundred kilobases
Daniel G. Gibson et al.
NATURE METHODS (2009)
Share Paper
